83237-49-4 Usage
Description
5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid, also known as 2-(3-(Carboxymethyl)-4-(phenylthio)-phenyl)propanoic Acid, is an organic compound that serves as an intermediate in the synthesis of pharmaceuticals. It is characterized by its carboxyethyl and phenylthio functional groups, which contribute to its chemical properties and reactivity.
Uses
Used in Pharmaceutical Industry:
5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid is used as an intermediate in the synthesis of Zaltoprofen (Z146000), an anti-inflammatory drug. Its role in the production process is crucial for creating the final drug product, which is designed to alleviate inflammation and associated symptoms.
As an intermediate, 5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid plays a significant role in the development of medications that can improve the quality of life for patients suffering from inflammatory conditions. Its specific chemical structure allows it to participate in reactions that lead to the formation of the desired active pharmaceutical ingredient, Zaltoprofen.
Check Digit Verification of cas no
The CAS Registry Mumber 83237-49-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,2,3 and 7 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 83237-49:
(7*8)+(6*3)+(5*2)+(4*3)+(3*7)+(2*4)+(1*9)=134
134 % 10 = 4
So 83237-49-4 is a valid CAS Registry Number.
InChI:InChI=1/C17H16O4S/c1-11(17(20)21)12-7-8-15(13(9-12)10-16(18)19)22-14-5-3-2-4-6-14/h2-9,11H,10H2,1H3,(H,18,19)(H,20,21)
83237-49-4Relevant articles and documents
Preparation of 2-(10,11-dihydro-10-oxodibenzo-[b,f]thiepin-2-yl) propionic acid
-
, (2008/06/13)
PCT No. PCT/JP97/02922 Sec. 371 Date Feb. 17, 1999 Sec. 102(e) Date Feb. 17, 1999 PCT Filed Aug. 22, 1997 PCT Pub. No. WO98/07717 PCT Pub. Date Feb. 26, 1998A process for preparation of 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid (i.e., Zaltoprofen) is performed by subjecting 2-(4-amino-3-carboxy-methylphenyl)propionic acid or its salt to diazotization and subsequent reaction with thiophenol to produce 2-(3-carboxymethyl-4-phenylthiophenyl)propionic acid or its salt, and subjecting the product to cyclization reaction. Other related processes and related compounds are also disclosed.